CAR-T Malignancy Reports Could Temper Excitement For Use Beyond Oncology

 
• By Sue Sutter
Magnifying glass
The US FDA is looking closely at 19 reports of T-cell malignancies with approved CAR-T products. • Source: Shutterstock

More from Drug Safety

More from Pink Sheet